Cardiorobotics, Inc. is developing advanced robotic technologies for use in a wide range of applications, including: medical, industrial, military, and law enforcement. The Company's highly articulated robotic probes have unlimited degrees of freedom, are teleoperated, and are able to steer a self-supported, non-linear path.

Within the medical field, the Company plans to serve a number of different specialist areas, including: minimally-invasive cardiac surgery, electrophysiology, laparoscopy, colonoscopy, and arthroscopy.

The Company is in its pre-clinical stage and expects to begin human clinical trials in 2009.